UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients

American journal of transplantation, 2013-06, Vol.13 (6), p.1541-1548

2013

Volltextzugriff (PDF)

High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant

American journal of transplantation, 2011-09, Vol.11 (9), p.1868-1876

2011

Volltextzugriff (PDF)

Class II Alloantibody and Mortality in Simultaneous Liver‐Kidney Transplantation

American journal of transplantation, 2013-04, Vol.13 (4), p.954-960

2013

Volltextzugriff (PDF)

Bortezomib for Acute Antibody‐Mediated Rejection in Liver Transplantation

American journal of transplantation, 2012-09, Vol.12 (9), p.2526-2531

2012

Volltextzugriff (PDF)

Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

American journal of transplantation, 2009-05, Vol.9 (5), p.1063-1071

2009

Volltextzugriff (PDF)

De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients

American journal of transplantation, 2013-06, Vol.13 (6), p.1541-1548

2013

Volltextzugriff (PDF)

Proteasome Inhibition Reduces Donor-Specific Antibody Levels

Transplantation proceedings, 2009, Vol.41 (1), p.105-107

2009

Volltextzugriff (PDF)

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

Transplantation, 2008-12, Vol.86 (12), p.1754-1761

2008

Volltextzugriff (PDF)

77: Donor-Specific Antibodies Correlate with Rejection in Heart Transplant Patients

The Journal of heart and lung transplantation, 2009-02, Vol.28 (2), p.S92-S92

2009

Volltextzugriff (PDF)

A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients

Transplantation, 2009-07, Vol.88 (1), p.23-29

2009

Volltextzugriff (PDF)

14: Human Leukocyte Antigen (HLA) Matching and Blood Group Identity/Compatibility and Heart Transplant Survival across Twenty Years: What Matters Early, What Matters Late?

The Journal of heart and lung transplantation, 2008, Vol.27 (2), p.S65-S65

2008

Volltextzugriff (PDF)

Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay

Transplantation, 2006-12, Vol.82 (11), p.1524-1528

2006

Volltextzugriff (PDF)

Preformed Class I DSA Testing: Standard vs. C1q vs. IgG3 Subclass Test Performance Comparison: Abstract# A15

Transplantation, 2014-07, Vol.98, p.876

2014

Volltextzugriff (PDF)

2-Hit Hypothesis: A Second “Hit” Increases the Risk for Death in Liver Allograft Recipients With Preformed Donor Specific Alloantibodies: Abstract# 2118

Transplantation, 2014-07, Vol.98, p.176

2014

Volltextzugriff (PDF)

De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients: De Novo DSA in Liver Transplantation

American journal of transplantation, 2013-04, p.n/a

2013

Volltextzugriff (PDF)

High Mean Fluorescence Intensity DSA and IgG3 Subclass DSA after Liver Transplantation Decrease Patient and Graft Survival: 1343

Transplantation, 2012-11, Vol.94 (10S), p.324

2012

Volltextzugriff (PDF)

High MFI Preformed Class I and De Novo Class II Donor Specific Antibodies Accelerate Fibrosis Progression after Liver Transplant in HCV-Infected Patients: 1144

Transplantation, 2012-11, Vol.94 (10S), p.6

2012

Volltextzugriff (PDF)

High MFI De Novo MHC Class II Donor Specific Antibody Formation Impairs Patient Survival after Liver Transplantation: 778

Transplantation, 2012-11, Vol.94 (10S), p.131

2012

Volltextzugriff (PDF)

Histocompatibility Testing Predicts Acute Rejection Risk in Early Corticosteroid Withdrawal Regimens

Transplantation proceedings, 2005-03, Vol.37 (2), p.809-811

2005

Volltextzugriff (PDF)

A significant role for histocompatibility in human islet transplantation

Transplantation, 2006-07, Vol.82 (2), p.180-187

2006

Volltextzugriff (PDF)

Global Cardiovascular Risk Under Early Corticosteroid Cessation Decreases Progressively in the First Year Following Renal Transplantation

Transplantation proceedings, 2005-03, Vol.37 (2), p.812-813

2005

Volltextzugriff (PDF)

Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes

The Journal of immunology (1950), 1992-06, Vol.148 (12), p.3847-3856

1992

Volltextzugriff (PDF)

African American Renal Transplant Recipients Benefit From Early Corticosteroid Withdrawal Under Modern Immunosuppression

Transplantation proceedings, 2005-03, Vol.37 (2), p.814-816

2005

Volltextzugriff (PDF)

Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients : Correlation to rejection and posttransplantation coronary artery disease

The Journal of heart and lung transplantation, 1998-08, Vol.17 (8), p.789-794

1998

Volltextzugriff (PDF)

Individualization of maintenance immunosuppressive therapy equalizes acute rejection risk in African American versus non–African American renal allograft recipients

Transplantation proceedings, 2001-09, Vol.33 (6), p.2977-2979

2001

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(148)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(203)
Deutsch
(12)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(68)
Humans
(58)
Biological And Medical Sciences
(46)
Male
(40)
Medical Sciences
(38)
Surgery
(38)
Transplantation
(33)
Female
(29)
Immunology
(28)
Animals
(27)
Middle Aged
(22)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(20)
Adult
(19)
Mice
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Physical Sciences
(18)
Time Factors
(18)
Fundamental Immunology
(17)
Graft Rejection - Immunology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients

High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant

Class II Alloantibody and Mortality in Simultaneous Liver‐Kidney Transplantation

Bortezomib for Acute Antibody‐Mediated Rejection in Liver Transplantation

Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients

Proteasome Inhibition Reduces Donor-Specific Antibody Levels

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

77: Donor-Specific Antibodies Correlate with Rejection in Heart Transplant Patients

A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients

14: Human Leukocyte Antigen (HLA) Matching and Blood Group Identity/Compatibility and Heart Transplant Survival across Twenty Years: What Matters Early, What Matters Late?

Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay

Preformed Class I DSA Testing: Standard vs. C1q vs. IgG3 Subclass Test Performance Comparison: Abstract# A15

2-Hit Hypothesis: A Second “Hit” Increases the Risk for Death in Liver Allograft Recipients With Preformed Donor Specific Alloantibodies: Abstract# 2118

De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients: De Novo DSA in Liver Transplantation

High Mean Fluorescence Intensity DSA and IgG3 Subclass DSA after Liver Transplantation Decrease Patient and Graft Survival: 1343

High MFI Preformed Class I and De Novo Class II Donor Specific Antibodies Accelerate Fibrosis Progression after Liver Transplant in HCV-Infected Patients: 1144

High MFI De Novo MHC Class II Donor Specific Antibody Formation Impairs Patient Survival after Liver Transplantation: 778

Histocompatibility Testing Predicts Acute Rejection Risk in Early Corticosteroid Withdrawal Regimens

A significant role for histocompatibility in human islet transplantation

Global Cardiovascular Risk Under Early Corticosteroid Cessation Decreases Progressively in the First Year Following Renal Transplantation

Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes

African American Renal Transplant Recipients Benefit From Early Corticosteroid Withdrawal Under Modern Immunosuppression

Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients : Correlation to rejection and posttransplantation coronary artery disease

Individualization of maintenance immunosuppressive therapy equalizes acute rejection risk in African American versus non–African American renal allograft recipients

Suchergebnisse filtern